PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW

Prenetics Global Ltd

Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2026

$19.02+0.50 (+2.70%)

Close on Oct 19, 2026

Community

Notes and questions about Prenetics Global from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Prenetics Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 1, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRE.

Revenue growth40.8% · median -20.1%

Gross margin50.3% · median 16.8%

Operating margin-157.2% · median -6.2%

Net margin-151.2% · median -6.5%

Advertisement
300 × 250